Portal de Periódicos da CAPES

Two alternate strategies for innate immunity to Epstein-Barr virus: One using NK cells and the other NK cells and γδ T cells

2017; Rockefeller University Press; Volume: 214; Issue: 6 Linguagem: Inglês

10.1084/jem.20161017

1540-9538

Zakia Djaoud, Lisbeth A. Guethlein, Amir Horowitz, Tarik Azzi, Neda Nemat‐Gorgani, Daniel Olive, David Nadal, Paul J. Norman, Christian Münz, Peter Parham,

Cytomegalovirus and herpesvirus research

Most humans become infected with Epstein–Barr virus (EBV), which then persists for life. Infrequently, EBV infection causes infectious mononucleosis (IM) or Burkitt lymphoma (BL). Type I EBV infection, particularly type I BL, stimulates strong responses of innate immune cells. Humans respond to EBV in two alternative ways. Of 24 individuals studied, 13 made strong NK and γδ T cell responses, whereas 11 made feeble γδ T cell responses but stronger NK cell responses. The difference does not correlate with sex, HLA type, or previous exposure to EBV or cytomegalovirus. Cohorts of EBV+ children and pediatric IM patients include both group 1 individuals, with high numbers of γδ T cells, and group 2 individuals, with low numbers. The even balance of groups 1 and 2 in the human population points to both forms of innate immune response to EBV having benefit for human survival. Correlating these distinctive responses with the progress of EBV infection might facilitate the management of EBV-mediated disease.